幹細胞の増殖と癌におけるDNAセンサーAIM2の重要な役割
Si Ming Man1, Qifan Zhu2, Liqin Zhu3
1Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Cell
|June 23, 2015
まとめ
生まれながらの免疫センサーAIM2は,腸の幹細胞の増殖を制御することによって,大腸がんから保護します. AIM2の喪失は,腸内微生物群の変化と組み合わせて,結腸腫瘍の発症を増加させます.
科学分野:
- 腫瘍学 腫瘍学
- 免疫学 免疫学とは
- 微生物学 微生物学とは
背景:
- 結腸直腸がん (CRC) は,がんによる死亡の主な原因である.
- Absent in Melanoma 2 (AIM2) の先天性免疫センサーの変異は,CRC患者において一般的です.
- 大腸腫瘍形成におけるAIM2の役割は不明である.
研究 の 目的:
- 大腸腫瘍の発達におけるAIM2の機能を調査する.
- CRCの感受性におけるAIM2,腸内幹細胞,腸内微生物群の相互作用を調査する.
主な方法:
- 大腸腫瘍の発達研究のためにAim2欠乏性マウスモデルを使用した.
- 炎症体関連サイトカインの産生と腸の幹細胞の増殖を評価した.
- 腸内微生物群のディスバイオシスと糞便微生物群移植の影響を調査した.
主要な成果:
- Aim2欠乏したマウスは,結腸腫瘍形成に対する感受性の高まりを示した.
- AIM2欠乏は,腸内幹細胞の制御不能な増殖と異常なWntシグナル伝達につながった.
- 腸内微生物群のディスバイオシスは,Aim2欠乏したマウスのCRC感受性を悪化させ,微生物群の交換によって改善された.
結論:
- AIM2は,結腸腫瘍発生を抑制する重要な宿主遺伝因子として作用する.
- CRCの発達において,AIM2と腸内微生物群の間には,相乗効果のある相互作用が存在します.
- AIM2をターゲットにし,腸内微生物群を調節することは,CRCの予防の可能性を示しています.
さらに関連する動画
関連する概念動画
DNA Damage can Stall the Cell Cycle
10.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle
3.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Cancer Stem Cells and Tumor Maintenance
6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance
2.3K
2.3K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K


